Stock 7071 AMVIS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Amvis Holdings, Inc.

Equities

7071

JP3128660002

Market Closed - Japan Exchange
Other stock markets
 07:00:00 26/04/2024 BST 		5-day change 1st Jan Change
2,199 JPY -4.56% Intraday chart for Amvis Holdings, Inc. -1.48% -26.82%
2023 Amvis Holdings, Inc. Reports Earnings Results for the Half Year Ended March 31, 2023 CI
2023 Amvis Holdings, Inc.(TSE:7071) added to FTSE All-World Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's high margin levels account for strong profits.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analyst opinion has improved significantly over the past four months.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The firm trades with high earnings multiples: 28.75 times its 2024 earnings per share.
  • Based on current prices, the company has particularly high valuation levels.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
AMVIS HOLDINGS, INC. Stock Amvis Holdings, Inc.
-26.82% 1.37B -
ORPEA Stock ORPEA
-24.26% 2.18B
B-
NATIONAL HEALTHCARE CORPORATION Stock National HealthCare Corporation
-1.23% 1.41B -
C+
SIENNA SENIOR LIVING INC. Stock Sienna Senior Living Inc.
+15.23% 706M -
B
ARVIDA GROUP LIMITED Stock Arvida Group Limited
-2.73% 464M
B-
SONIDA SENIOR LIVING, INC. Stock Sonida Senior Living, Inc.
+240.37% 432M -
D+
MEDITERRANEAN TOWERS LTD. Stock Mediterranean Towers Ltd.
-7.77% 322M - -
HUMANA AB Stock Humana AB
+1.24% 124M
B
GOLDEN HOUSE LTD Stock Golden House Ltd
+39.04% 88.82M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 7071 Stock
  4. Ratings Amvis Holdings, Inc.